Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

66 resultsUpdated October 23, 2026
2

Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis

Journal of Ethnopharmacology 264 (2020)

Yuan Zhou; Rong Wu; Feifei Cai; Wenjun Zhou; Yi-Yu Lu; Hui Zhang; Qilong Chen; Shi-Bing Su

3

High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes

Scientific Reports 11(1) (2021)

Haruka Saito; Hayato Tanabe; Akihiro Kudo; Noritaka Machii; Moritake Higa; Satoshi Yamaguchi; Gulinu Maimaituxun; Kazumichi Abe; Atsushi Takahashi; Kenichi Tanaka; Koichi Asahi; Hiroaki Masuzaki; Hiromasa Ohira; Junichiro James Kazama; Michio Shimabukuro

4

De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke

Neuropsychiatric Disease and Treatment Volume 13 (2017)

Fan Gao; Chen Chen; Jun Lu; Jie Zheng; Xiancang Ma; Xingyun Yuan; Kang Huo; Jianfeng Han

5

A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis

BMC Genomics 19(1) (2018)

Jie Liu; Yue Xiao; Xikun Wu; Lichun Jiang; Shurong Yang; Zhi‐Ming Ding; Zhuo Fang; Haiqing Hua; Mark Kirby; Jianyong Shou

6

The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients

Journal of Clinical Gastroenterology 52(3) (2017)

Amandeep Singh; Phuc Le; Maajid Mumtaz Peerzada; Rocío López; Naim Alkhouri

7

Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers

Contemporary Clinical Trials 97 (2020)

Stephen A. Harrison; Salvatore Calanna; Kenneth J. Cusi; Martin Linder; Takeshi Okanoue; Vlad Ratziu; Arun Jayant Sanyal; Anne‐Sophie Sejling; Philip Noel Newsome

8

Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study

Korean Journal of Radiology 18(6) (2017)

Shuangshuang Xie; Qing Li; Yue Cheng; Yu Zhang; Zhizheng Zhuo; Guiming Zhao; Wen Shen

9

Phase angle as a severity indicator for liver diseases

Nutrition 70 (2019)

Ana Paula Pagano; Juliana Maria Faccioli Sicchieri; Isabela Laurencio Schiavoni; D. Barbeiro; Camila Sanches Manca; Bruna Ramos da Silva; Amanda Escobar Bezerra; Lívia Cristina Mendonça Pinto; Roberta Chaves Araújo; Andreza Corrêa Teixeira; Paula Garcia Chiarello

10

Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease

Marine Drugs 20(6) (2022)

Jiayao Feng; Yongjian Liu; Jiajia Chen; Yan Bai; Jincan He; Hua Cao; Qishi Che; Jiao Guo; Zhengquan Su

11

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

Diagnostics 11(5) (2021)

Sebastian Zenovia; C Stanciu; Catalin Victor Sfarti; Ana-Maria Sîngeap; Camelia Cojocariu; Irina Gîrleanu; Mihaela Dimache; Stefan Andrei Chiriac; Cristina Maria Muzica; Robert Năstasă; Laura Huiban; Tudor Cuciureanu; Anca Victorita Trifan

12

Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis

World Journal of Hepatology 14(4) (2022)

Layal Al Nadaf; Mohammed Hussein Kamareddine; Emilie Fayad; Aniqa Hussain; Said G Farhat

13

Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

Cureus 13(8) (2021)

Bandana Kumari; Ramesh K. Kumar; Sadhana Sharma; Ayan Banerjee; Visesh Kumar; Pawan Kumar; Neha Chaudhary; Sushil Kumar; Khushboo Raj

14

FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH

Liver International 44(12) (2024)

Laura Martínez‐Arenas; Carmen Vinaixa; Isabel Conde; Sara Lorente; Fernando Díaz‐Fontenla; Patrice Marqués; Judith Pérez‐Rojas; Eva María Montalvá; Ângela Carvalho‐Gomes; Marina Berenguer

15

Diagnostic performance of new BAST score versus FIB-4 index in predicating of the liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease

European journal of medical research 29(1) (2024)

Eman Helal; Fatma Elgebaly; Nasser Mousa; Sherif Elbaz; Mostafa Abdelsalam; Eman Abdelkader; Amr Ali Mohamed Abdelgawwad El‐Sehrawy; Niveen El‐Wakeel; Ola El-Emam; Manal Hashem; Alaa Elmetwalli; Shimaa Mansour

16

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease

Egyptian Liver Journal 10(1) (2020)

Ahmed M. F. Mansour; Essam Bayoumy; Ahmed Mohamed ElGhandour; Mohamed Darwish El-Talkawy; Sameh M. Badr; Ahmed Elmetwally Ahmed

17

Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway

Biomedicine & Pharmacotherapy 128 (2020)

Manman Chen; Jing-Wei Xing; Danqing Pan; Xiuhua Peng; Pengfei Gao

18

Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl4-induced liver fibrosis in rats

Chinese Medicine 16(1) (2021)

Yu Xiong; Jinyuan Hu; Chen Xuan; Jiayu Tian; Kaiyue Tan; Zhiwei Chen; Yan Luo; Xuqin Du; Junxiong Cheng; Lanyue Zhang; Wenfu Cao

19

FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning

Medicine 102(34) (2023)

Yuping Ding; Zuoyu Wang; Haiyan Niu; Quanjun Deng; Yanan Wang; Shihai Xia

20

Evaluation of hepatosteatosis in patients with chronic hepatitis B virus infection

Arab Journal of Gastroenterology 24(1) (2022)

Merve Sefa Sayar; Dilek Bulut; Ali Acar

21

Predictors of Hepatic Fibrosis in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease

Biomedicines 12(11) (2024)

Joana D’Arc Matos França de Abreu; Rossana Santiago de Sousa Azulay; Vandílson Pinheiro Rodrigues; Sterffeson Lamare Lucena de Abreu; Maria da Glória Tavares; Flávia Coelho Mohana Pinheiro; Clariano Pires de Oliveira Neto; Caio Andrade; Alexandre Nogueira Facundo; Adriana Guimarães Sá; Patrícia Ribeiro Azevedo; Ana Gregória Ferreira Pereira de Almeida; Debora Camelo de Abreu Costa; Rogério Soares Castro; Marcelo Magalhães; Gilvan Cortês Nascimento; Manuel dos Santos Faria; Adalgisa de Souza Paiva Ferreira

23

Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study

Expert Review of Proteomics 17(7-8) (2020)

Paweł Małecki; Joanna Tracz; Magdalena Łuczak; Magdalena Figlerowicz; Katarzyna Mazur‐Melewska; Wojciech Służewski; Anna Mania

24

Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease

Diagnostics 12(4) (2022)

Anca Victorita Trifan; Adrian Rotaru; Remus Stafie; Ermina Stratina; Sebastian Zenovia; Robert Năstasă; Laura Huiban; Tudor Cuciureanu; Cristina Maria Muzica; Stefan Andrei Chiriac; Irina Gîrleanu; Ana-Maria Sîngeap; Catalin Victor Sfarti; Camelia Cojocariu; C Stanciu

25

Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease

Diabetes Metabolic Syndrome and Obesity Volume 14 (2021)

Muhammad Shah Alam; Abul B. M. Kamrul-Hasan; Syeda Tanzina Kalam; SM Mizanur Rahman; Mohammad Izazul Hoque; Md Belalul Islam; Ajit Paul

26

Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes

Nutrition Metabolism and Cardiovascular Diseases 33(9) (2023)

Kálmán Benedikt Bódis; Maria Bombrich; Martin Schön; Birgit Knebel; Oana‐Patricia Zaharia; Gidon Josia Bönhof; Yanislava Karusheva; Klaus Straßburger; Yuliya Kupriyanova; Jörg Kotzka; Rainer Guthoff; Vera B. Schrauwen‐Hinderling; Hadi Al‐Hasani; Volker Burkart; Julia Szendroedi; Robert J. Wagner; Daniel F. Markgraf; Michael Roden

27
28

Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases

Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis 7.2(2) (2023)

Nasser Mousa; Ahmed El-Eraky; Mona Arafa; Hatem Elalfy; Raghda E. Farag; Ahmed Abdel‐Razik; Talaal Amer

29

Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease

Journal of Clinical Medicine 13(21) (2024)

Iván Ferraz‐Amaro; Alejandro Hernández-Camba; Marta Carrillo Palau; Noemi Hernández Alvarez-Buylla; Antonia de Vera-González; Alejandra González Delgado; Elena Heras-Recuero; Miguel Ángel González-Gay

30

Diagnostic Accuracy of Red Cell Distribution Width to Platelet Ratio for the Prediction of Liver Fibrosis in Patients With Chronic Liver Disease From Eastern India

Cureus 17(4) (2025)

D Pavan Sai Kumar Rao; Shubhransu Patro; Vibha Sharma; Arushi Choudhary; Shubham Desale; Preetam Nath

32

The Fibrosis-4 Index Is Useful for Predicting Mortality in Patients with Pulmonary Hypertension due to Left Heart Disease

International Heart Journal 60(5) (2019)

Tetsuro Yokokawa; Koichi Sugimoto; Akiomi Yoshihisa; Takuya Goto; Tomofumi Misaka; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Takafumi Ishida; Yasuchika Takeishi

33

Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical Study

International Journal of Molecular Sciences 22(18) (2021)

Ana Aguiar; Jaluza Luana Carvalho de Queiroz; Pedro Paulo de Andrade Santos; Christina da Silva Camillo; Alexandre Coelho Serquiz; Izael de Sousa Costa; Gerciane Silva de Oliveira; Ana Francisca Teixeira Gomes; Lídia Leonize Rodrigues Matias; Rafael O. Costa; Thaís Souza Passos; Ana Heloneida de Araújo Morais

34

Prevalence and clinical characteristics of NAFLD in chronic liver disease patients from King Abdulaziz University Hospital, Jeddah

Saudi Journal of Medicine and Medical Sciences 8(2) (2020)

Hind I. Fallatah; Ammar AlDabbagh; MohammeadT Hiejazi; Sulaiman A. Hanbazazah; AliO Hussein; Majed A. Al-Sahafi; Hisham Osman Akbar

36

Telmisartan improves the metabolic, hematological and inflammasome indices in non-alcoholic fatty liver infiltration: A pilot open-label placebo-controlled study

Electronic Journal of General Medicine 16(3) (2019)

Marwan S.M. Al-Nimer; Vian Ahmed Wasta Esmail; O N Mohammad

37

Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease

Cureus 14(1) (2022)

Bandana Kumari; Sadhana Sharma; Ramesh K. Kumar; Satish Pundlik Dipankar; Bijaya Nanda Naik; Ayan Banerjee; Sushil Kumar

38

Shear wave elastography reveals a high prevalence of liver fibrosis in overweight or obese Hispanic youth

Journal of Ultrasonography 20(82) (2020)

Sanjeet Sandhu; Carisse M. Orsi; Gary L. Francis; Zhu Wang; Roman A. Fernandez; Naim Alkhouri

40

Is Aspartate Aminotransferase to Platelet Ratio Index a Better Noninvasive Score for Predicting Advanced Fibrosis in Nonalcoholic Fatty Liver Disease Patients?

Euroasian Journal of Hepato-Gastroenterology 14(1) (2024)

Priyansh Deven Bhayani; Sarojini Ashok Parameswaran; Kallipatti Ramasamy Palaniswamy; Piramanayagam Paramasivan; Natarajan Murugan

41

Platelet-derived growth factor receptor-β as a non-invasive biomarker for liver fibrosis prediction in Egyptian diabetic patients with metabolic-associated fatty liver disease

BMC Gastroenterology 25(1) (2025)

Hanaa Mostafa Badran; Maha Elsabaawy; Mai Magdy; Hazem Metwaly Omar; Olfat Mohamed Hendy; Eman Kamal Awaad; Maryam Alkhalifa; Mai Abozeid

42

Platelet Proteomics: A Glimpse Into Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis

Hepatology Research 56(4) (2025)

Iulia Minciună; Maria Iacobescu; Ioana Rusu; Oana Nicoară-Farcău; Petra Fischer; Maria-Andreea Soporan; Ioana-Ecaterina Pralea; Horia Ştefănescu; Cristina Adela Iuga; Bogdan Procopeț

43

Correlation between Serum Ferritin Levels and Liver Stiffness measured by Fibroscan in patients with Chronic Hepatitis C

Pakistan Journal of Medical Sciences 36(3) (2020)

Saba Latif; Quratulain Kalam; Bader Faiyaz Zuberi

44

Non-invasive Methods in Diagnosis of Nonalcoholic Fatty Liver Disease

The Egyptian Journal of Hospital Medicine 83(1) (2021)

Khaled Hemida; Hany Haroun; Inas Elkhedr Mohamed; Mostafa Mahmoud

45

CORRELATION OF FIB-4 AND APRI SCORE WITH FIBRO SCAN SCORE TO PREDICT FIBROSIS IN OBESE TYPE-2 DIABETIC PATIENTS.

Student s Journal of Health Research Africa 4(12) (2023)

Amit Kumar Das; Anuj Sharma; Mohammad Zahid Labrez

46

Prevalence of non-alcoholic steatohepatitis in a general population of North Karnataka

THE SCIENTIFIC TEMPER 14(04) (2023)

Geeta S Desai; Santosh Hajare; Sangeeta N Kharde

48

Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans

Journal of Viral Hepatitis 27(10) (2020)

Martin Tibuakuu; Caroline J Jjingo; Gregory Dale Kirk; David L. Thomas; Ronald Henry Gray; Victor Ssempijja; Fred Kakaire Nalugoda; David Serwadda; Ponsiano Ocama; Christopher Opio; David Erwin Kleiner; Thomas C. Quinn; Steven James Reynolds

50

ASSESSMENT OF LIVER STIFFNESS IN NONALCOHOLIC FATTY LIVER DISEASE

Zagazig University Medical Journal 24(8) (2018)

51

Role of Controlled Attenuation Parameter in Metabolic Associated Fatty Liver Disease Patients

Afro-Egyptian Journal of Infectious and Endemic Diseases 0(0) (2022)

Yehia El-Khashab; Tarik I. Zaher; Noha Shaheen; Sameh Abdel Monem

52

Transient Elastography and its Correlation with Biochemical Scores in patients with Metabolic associated fatty liver disease

Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis 6.3(3) (2022)

Ahmed Mohammed Mosaad; Hatem Elalfy; Talaal Amer; Mona Arafa

54

Liver Fibrosis Biomarker Validation Using Machine Learning Algorithms

Laboratory Medicine Online 13(3) (2023)

Min-Kyeong Kim; Heon‐Ju Kwon; Kangsu Shin; Hyosoon Park; Hee‐Yeon Woo; Chang‐Hun Park; Min‐Jung Kwon

55

Fibroscan and Low-Density Lipoprotein Versus Non-invasive Markers (APRI test and FIB-4) As Determinants of Severe Liver Fibrosis in Egyptian Diabetic Patients With Non-Alcoholic Fatty Liver Disease

Al-Azhar International Medical Journal /Al-Azhar International Medical Journal 4(6) (2023)

Esmail Anwar Esmail; Mohamed Elnadry; Mohamed Mousa Hegazy; Mohamed Mahmoud Abdelhalim; Mohamed Hassani Barbari

56

Liver Stiffness Measurement is Useful in Predicting Type 2 Diabetes Mellitus Among Nonalcohol Fatty Liver Disease Patients

Diabetes Metabolic Syndrome and Obesity Volume 17 (2024)

Yuping Ding; Guiqiang Wang; Quanjun Deng; Mei Yang; Jinghua Li; Zuoyu Wang; Haiyan Niu; Shihai Xia

57

The ratio of high aspartate aminotransferase to alanine aminotransferase: an independent risk factor associated with poor prognosis in IgA nephropathy

Clinical and Experimental Nephrology 28(11) (2024)

Hailang Wei; Bingqing Liao; Qi Zhou; Xuhua Zhou; Yue Zhong; Yanbin Hao; Fuhua Xie; Runxiu Wang

58

Comparison of Fibrosis-4 with FibroScan for Liver Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease Patients: A Cross-sectional Study

Journal of the Dow University of Health Sciences 18(2) (2024)

Fahad Kakar; Arif Rasheed Siddiqui; Saad Khalid Niaz; Syed Afzal Ul Haq Haqqi; Zea Ul Islam Farrukh; Muhammad Danish Ashraf Wallam; Muhammad Umar Farooq; Sayed Rohail Ahmed Rizvi

60

A clinical case of non-alcoholic fatty liver disease with polycystic ovary syndrome

Terapevt (General Physician)(7) (2025)

Дударева Лариса Андреевна; Tkachev Av; А. M. Aslanov; Galina N. Tarasova; В. А. Косенко; Мазовка Карина Евгеньевна; E. N. Veselova; Мкртчян Лиана Сирекановна; L.V. Sudyina; Yu. Yu. Chebotareva

61

Modeling the progression of NAFLD: a multi-state Markov approach based on BMI classification in the Chinese population

Exploration of Endocrine and Metabolic Diseases 2 (2025)

Jianmin Tang; Aheyeerke Halengbieke; Chao Tong; Xuetong Ni; Tengrui Cao; Yumei Han; Shuo Chen; Linrun Kong; Xinghua Yang

62

Clinical utility of non-invasive markers in the assessment of liver fibrosis among type 2 diabetes mellitus patients

Turkish Journal of Biochemistry 51(4) (2026)

Thilak Priyantha Weerarathna; Keddagoda Gamage Piyumi Wasana; Iroshani Kodikara; Suneth Ruwan Weerarathna

64

Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a cross-sectional diagnostic accuracy study

BMC Gastroenterology 26(1) (2026)

Hossein Bagheri; Niloofar Seighali; Mohammad Sadra Gholami Chahkand; Mahmood Bakhtiyari; Fateme Seighali; Fatemeh Jodeiri; Mohsen Rajabnia

65

Creatinine-to-body weight ratio as a marker of metabolic dysfunction and obesity-related steatosis in Egyptian patients

Egyptian Liver Journal 16(1) (2026)

Shimaa Ebrahim; Ebtesam Shady; Shimaa Moustafa Mansour